News Articles

The ISSCR Comments on EMA Draft Guidance on Registry-based Studies

Full story
The ISSCR Signs Ad Hoc Group for Medical Research Coalition Letter on NIH to President-elect Biden

Full story
The ISSCR Shares Comments on the European Medicines Agency's Network Strategy to 2025

Full story
The ISSCR Urges HHS to Reject Ethics Advisory Board Recommendations on Fetal Tissue Research

Full story
The ISSCR Sends Letter to WHO Regarding Their Genome Editing Consultation

Full story
ISSCR Statement on NIH Human Fetal Tissue Ethics Advisory Board Report

Full story
ISSCR Statement on the NIH Human Fetal Tissue Research Ethics Advisory Board Meeting

Full story
ISSCR Statement on Proposed Cuts to Scientific Research in Europe

Full story
The ISSCR Signs Two Letters Opposing U.S. Administration’s Immigration Policies

Full story
ISSCR Urges FDA and EMA to Enforce Regulation of Clinics Offering Unproven and Unapproved Stem Cell-based Interventions

Full story
ISSCR Shares Recommendations for Proposed Genome Editing Registry with WHO

Full story
ISSCR and 100 Scientific Organizations Urge the Administration to Lift the Restrictions on Fetal Tissue Research

Full story
ISSCR Announces Endorsement for California Initiative to Fund Stem Cell Research

Full story
ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products

The ISSCR writes UK agency to urge for increased enforcement activities to prevent the marketing and commercialization of stem cell-related products.
Full story
ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse

The ISSCR issues a comment letter urging that more efforts must be made to prevent the ClinicalTrials.gov database from being abused by clinics marketing unproven stem cell interventions.
Full story